5HTT promoter polymorphism in idiopathic pulmonary arterial hypertension

International Journal of Human Genetics

Volumn 11, Issue 2, 2011, Pages 111-115

  Shivani, V ^a   Sujana, K ^a   Sastry, B K S ^b   Nallari, Pratibha ^a  

^a OSMANIA UNIVERSITY   (India)

^b CARE HOSPITAL   (India)

Author keywords

5HTT promoter polymorphism; Frequency; Hyperplasia; IPAH; Mean pulmonary artery systolic pressure; Serotonin

Indexed keywords

AGAROSE; ETHIDIUM BROMIDE;

5 HYDROXY TRYPTAMINE TRANSPORTER GENE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE FUNCTION; GENE LOCATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HIGH RISK PATIENT; HUMAN; IDIOPATHIC DISEASE; INDEL MUTATION; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MOLECULAR PATHOLOGY; POLYMERASE CHAIN REACTION; PROMOTER REGION; PULMONARY HYPERTENSION; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE;

EID: 84856619122     PISSN: 09723757     EISSN: None     Source Type: Journal    
DOI: 10.1080/09723757.2011.11886132     Document Type: Article

References (22)

1. Eddahibi S, Hanoun N, Lanfumey L, Lesch KP, Raffestin B, Hamon M et al. 2000. Attenuated hypoxic pulmonary hypertension in mice lacking the 5- hydroxytryptamine transporter gene. J Clin Invest, 105: 1555-1562.
2. Eddahibi S, Humbert M, Fadel E, Raffestin B, Darmon M et al. 2001.Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest, 108: 1141-1150.
3. Eddahibi S, Chaouat A, Morrell N, Fadel E, Fuhrman C et al. 2003. Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary disease. Circ, 108(15): 1839-1844.
4. Fanburg BL, Lee SL 2000. A role for the serotonin transporter in hypoxia induced pulmonary hypertension. J Clin Invest, 105(11): 1521-1523.
5. Fishman AP 2004. Primary pulmonary arterial hypertension: A look back. J Am Coll Cardiol, 43: 2-4.
6. Ghamra, ZW, Dweik RA 2003. Primary pulmonary hypertension: An overview of epidemiology and pathogenesis. Cleaveland Clinic Journal of Medicine,70 Suppl 1: S2-8
7. Lahari D, Nurunberger J 1991. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res, 19: 5444.
8. Lee SL, Wang WW, Moore BJ, Fanburg BL 1991. Dual effect of serotonin on growth of bovine pulmonary artery smooth muscle cells in culture. Circ Res, 68: 1362-1368.
9. Lesch KP, Balling U, Gross J, Strauss K, Wolozin BL et al. 1994. Organization of human serotonin transporter gene. J Neural Transm, 95: 157-164.
10. Machado RD, James V, Southwood M, Harrison RE, Atkinson C et al. 2005. Investigation of second genetic hits at the BMPR2 locus as a modulator of disease progression in familial pulmonary arterial hypertension. Circ, 111: 607-613.
11. Machado RD, Koehler R, Glissmeyer E, Veal C, Suntharalingam J et al. 2006. Genetic association of the serotonin transporter in pulmonary arterial hypertension. Am J Respir Crit Care Med, 173: 793-797.
12. MacLean MR, Deuchar GA, Hicks MN, Morecroft I, Shen S et al. 2004. Overexpression of the 5-hydroxytryptamine transporter gene: Effect on pulmonary hemodynamics and hypoxia-induced pulmonary hypertension. Circ, 109(17): 2150-2155.
13. Marcos E, Fadel E, Sanchez O, Humbert M, Dartevelle P et al. 2004. Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension. Circ Res, 94: 1263-1270.
14. McQuillan BM, Picard MH, Leavitt M, Weyman AE 2001. Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects. Circ, 104: 2797.
15. Olson TP, Snyder EM, Frantz RP, Turner ST, Johnson BD 2007. Repeat length polymorphism of the serotonin transporter gene influences pulmonary artery pressure in heart failure. Am Heart J, 153(3):426-32.
16. Pakala R, Willerson JT, Benedict CR 1994. Mitogenic effect of serotonin on vascular endothelial cells. Circ, 90: 1919-1926.
17. Rabinovitch M, Gamble W, Nadas AS, Miettinen O, Reid L 1979. Rat pulmonary circulation after chronic hypoxia: Hemodynamic and structural features. Am J Physiol, 236: H818-H827.
18. Ramamoorthy S, Bauman AL, Moore KR, Han H, Yang-Feng T et al. 1993. Antidepressant- and cocainesensitive human serotonin transporter: Molecular cloning expression,and chormosomal localization. Proc Natl Acad Sci USA, 90: 2542-2546.
19. Rothman RB, Ayestas MA, Dersch CM, Baumann MH 1999. Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates. Implications for primary pulmonary hypertension. Circ, 100: 869-875.
20. Rubin LJ 1997. Primary pulmonary hypertension. NEJM, 336: 111-117.
21. Vachharajani A, Saunders S 2005. Allelic variation in the serotonin transporter (5HTT) gene contributes to idiopathic pulmonary hypertension in children. Biochem Biophy Res Commun, 334: 376-379.
22. Yuan XJ, Rubin LJ 2005. Pathogenesis of pulmonary arterial hypertension: The need for multiple hits. Circ, 111: 534-538.